Insulin in type 2 diabetesStudies the use of insulin for the treatment of patients with type 2 diabetes. Time to initiate insulin in patients with the disease; Benefits of insulin for patients; Types of insulin; Ro...
2、2型糖尿病(T2DM,type 2 diabetes)=非胰岛素依赖型糖尿病(NIDDM,non-Insulin Dependent Diabetes Mellitus):2型糖尿病早期的核心发生机制(始发因素)是“胰岛素抵抗(insulin resistance)”,即患者体内胰岛素的靶器官和靶组织对胰岛素的应答程度降低了,也就是说,在2型糖尿病发病早期,患者体内胰岛素水平并没有显著降低...
Weekly Insulin May Be as Effective as Once Daily for Type 2 Diabetes Samantha Anderer JAMA. 2024;332(17):1417. doi:10.1001/jama.2024.20116 Full Text Slow-acting basal insulin, typically injected daily, can help stabilize glucose levels between meals in individuals with diabetes. But results fr...
SKYLER J.S. ET AL: ' Insulin therapy in type II diabetes. ' POSTGRADUATE MEDICINE., [Online] vol. 101, no. 2, February 1997, pages 1 - 17, XP002080749 Retrieved from the Internet:Skyler JS. Insulin therapy in type II diabetes: who needs it, how much of it and for how long?
Unlike type 1 diabetic patients, who have no significant insulin secretion and require insulin therapy from the disease onset, a prominent feature in the early stages of type 2 diabetes is insulin resistance with hyperinsulinemia. Therefore, improving insulin sensitivity by diet, exercise, and weight...
In type 2 diabetes, some people will already show signs of nerve damage when they’re diagnosed. This is an instance where getting the blood glucose level under control can prevent further damage. There are several forms of diabetic neuropathy: peripheral, autonomic, proximal, and focal. Diabetic...
March 14, 2012 — The addition of insulin to the treatment regimen of patients with type 2 diabetes does not significantly increase the incidence of vascular events, according to a study involving nearly 15,000 participants. Any perceived differences in vascular events between the 2 groups is ...
Basal Insulin Therapy in Type 2 Diabetes OBJECTIVE—To determine the safety and efficacy of the long-acting analog insulin glargine compared with NPH insulin in patients with type 2 diabetes who w... J Rosenstock,SL Schwartz,CM Clark,... - 《Diabetes Care》 被引量: 715发表: 2001年 Initiati...
There are two completely different diseases known as diabetes. Type 1 is an autoimmune condition that often starts in childhood or adolescence. Type 2 is a metabolic disorder sometimes associated with lifestyle. In both cases, the insulin-secreting beta cells in the pancreas die, albeit at differ...
Afrezza, a rapid-acting inhaled insulin, is FDA-approved for use before meals for both type 1 and type 2 diabetes. The drug peaks in your blood in about 15-20 minutes and it clears your body in 2-3 hours. It must be used along with long-acting insulin in people with type 1 diabete...